Ukrainian company, Ekomed LLC, published clinical study of phytoconcentrates Dzherelo (Immunoxel), Lizorm and Svitanok used as an adjunct immunotherapy against multi-drug (MDR-TB), (XDR-TB), and in patients with concomitant HIV and Mycobacterium tuberculosis infections. The study appeared in the current issue of International Journal of Biomedical and Pharmaceutical Sciences (Vol. 2; Pages 59-64, 2008). Abstract of the paper can be found online
(more...)